APA (7th ed.) Citation

Vermorken, J. B., Guigay, J., Mesia, R., Trigo, J. M., Keilholz, U., Kerber, A., . . . Brummendorf, T. H. (2011). Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: Findings of the phase I part. British Journal of Cancer, 104(11), 1691. https://doi.org/10.1038/bjc.2011.152

Chicago Style (17th ed.) Citation

Vermorken, J. B., J. Guigay, R. Mesia, J. M. Trigo, U. Keilholz, A. Kerber, U. Bethe, M. Picard, and T. H. Brummendorf. "Phase I/II Trial of Cilengitide with Cetuximab, Cisplatin and 5-fluorouracil in Recurrent And/or Metastatic Squamous Cell Cancer of the Head and Neck: Findings of the Phase I Part." British Journal of Cancer 104, no. 11 (2011): 1691. https://doi.org/10.1038/bjc.2011.152.

MLA (9th ed.) Citation

Vermorken, J. B., et al. "Phase I/II Trial of Cilengitide with Cetuximab, Cisplatin and 5-fluorouracil in Recurrent And/or Metastatic Squamous Cell Cancer of the Head and Neck: Findings of the Phase I Part." British Journal of Cancer, vol. 104, no. 11, 2011, p. 1691, https://doi.org/10.1038/bjc.2011.152.